 .  may cause drug-drug interactions for patients taking drugs to treat HIV/AIDS or . , according to a new statin warning from the FDA. The agency singled out atorvastatin (Lipitor), rosuvastatin (Crestor), and simvastatin (Zocor) for the new warnings and restated a warning about mixing lovastatin (Mevacor) with HIV and HCV drugs.. Today's FDA safety communication follows label changes announced Tuesday that added cautions about new onset diabetes and transient memory problems for users of any of the .  drugs in the statin class.. The FDA said that protease inhibitors taken with atorvastatin, rosuvastatin, simvastatin, or lovastatin increase the concentration of statins in the blood, which increases the risk for muscle injuries, including risk for rhabdomyolysis, which can cause permanent damage to the kidneys.. Specifically, the agency said atorvastatin is contraindicated with a number of hepatitis C drugs and should be used with caution — at the lowest effective dose — among patients taking . .. Rosuvastatin should be limited to 10 mg daily in patients taking certain hepatitis C medications.. The FDA said simvastatin — like lovastatin — is contraindicated in patients taking "HIV protease inhibitors, boceprevir or telaprevir."